<SEC-DOCUMENT>0001000694-24-000026-index.html : 20240429
<SEC-HEADER>0001000694-24-000026.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429080102
ACCESSION NUMBER:		0001000694-24-000026
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429
EFFECTIVENESS DATE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26770
		FILM NUMBER:		24886663

	BUSINESS ADDRESS:	
		STREET 1:		700 QUINCE ORCHARD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
		BUSINESS PHONE:		240-268-2000

	MAIL ADDRESS:	
		STREET 1:		700 QUINCE ORCHARD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>novavax2023annualreport-fi.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: novavax2023annualreport-fi.pdf

</DOCUMENT>
</SEC-DOCUMENT>